Liquid chromatography–mass spectrometry (LC–MS) was used to identify the concentrations of psychoactive drugs in water and fish from the River Fyris (Uppsala, Sweden) Scientists from Umeå University, Sweden, published the findings in Science earlier this year.1
Concerns have been raised throughout the scientific community about the potential effects of pharmaceuticals on the environment. Drugs are designed to be highly stable and also to be released from the body. Consequently, many pharmaceutical compounds survive wastewater treatment and are released into the aquatic environment.
Liquid chromatography–mass spectrometry (LC–MS) was used to identify the concentrations of psychoactive drugs in water and fish from the River Fyris (Uppsala, Sweden) Scientists from Umeå University, Sweden, published the findings in Science earlier this year.1
One class of pharmaceuticals commonly prescribed globally for the treatment of anxiety are benzodiazepines, including oxazepam. Scientists performed LC–MS to discover the presence of oxazepam in the River Fyris at concentrations reported to be similar to those in other American and European waters. The source of the drugs was thought to be an upstream wastewater treatment plant that released treated effluent into the river.Samples were taken from the treated effluent, the river and also from the wild European Perch (Perca fluviatilis) that reside in the River Fyris. According to the results, the concentration of oxazepam was six times higher in the muscle tissues of fish samples compared to the concentration in water samples, which indicates bioaccumulation of oxazepam in the food chain.
Oxazepam acts on GABA receptors in the human brain, but these are also found throughout the animal kingdom. Therefore the investigators hypothesized that the drugs could have a behavioural impact on the resident perch, even though the concentrations of the drug in the water samples were relatively low.
Juvenile perch were exposed to either an environmentally relevant or high concentration of oxazepam in the laboratory. Exposure to the lower concentration reported to be environmentally relevant resulted in a “personality” change within the fish. The fish became bolder, more active and displayed reduced sociality. In addition, an increase in the food consumption of the fish was observed. The data suggests that oxazepam increases the predation of the fish, which, as in any ecosystem, could have a far-reaching impact.
The effects of the oxazepam on the behaviour and feeding efficiency of perch is alarming and potentially ecosystem-changing according to Tomas Brodin, lead author of the study. He added that the concentrations of oxazepam found to have an effect were lower than found in other waters in Europe, for example France.
However, although a clear impact on the aquatic ecosystem, Brodin told The Column “At this point there are no reasons to reduce consumption of perch as human food as you would have to eat 4000 kg of perch to get equivalent amounts of oxazepam that can be found in one prescribed pill.”The indirect effects on the aquatic ecosystem are a possible cause for concern with the potential to increase the frequencies of algal blooms, reduce fish stocks and other unanticipated effects, according to Brodin.
Reference:
1. T. Brodin et al, Science 339, 814 (2013)
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.